<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363279">
  <stage>Registered</stage>
  <submitdate>14/11/2012</submitdate>
  <approvaldate>19/11/2012</approvaldate>
  <actrnumber>ACTRN12612001221842</actrnumber>
  <trial_identification>
    <studytitle>Randomised Double Blind Placebo Controlled Study to Determine the Effects of Vitamin D supplementation on Platelet and Vascular function in patients with Vitamin D insufficiency and known Coronary artery or peripheral vascular disease</studytitle>
    <scientifictitle>Randomised Double Blind Placebo Controlled Study to Determine the Effects of Vitamin D supplementation on Platelet and Vascular function in patients with Vitamin D insufficiency and known Coronary artery or peripheral vascular disease</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Coronary artery disease</healthcondition>
    <healthcondition>peripheral vascular disease</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Vitamin D3 (Cholecalciferol) 2000IU once daily for twelve (12) weeks- oral capsule</interventions>
    <comparator>Placebo, Microcellulose capsule</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Follow up of both groups after 12 weeks with repeat testing of platelet function via citrated blood collection and tested by Platelet Aggregometry method.</outcome>
      <timepoint>12 weeks after randomisation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Endothelial function test assessed by venous occlusion plethysmography and edoPat.</outcome>
      <timepoint>12 Weeks after randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Arterial Stiffness test assessed by venous occlusion plethysmography and edoPat.</outcome>
      <timepoint>12 Weeks after randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Measured Vitamin D level 25-50 nanomol/L
Not on Vitamin D replacement therapy for previous 3 months
Known history of CAD or PVD
Currently taking Aspirin as single anti-platelet therapy
Other appropriate arterial disease risk factor reduction therapy</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Age &lt; 40yrs or &gt; 85yrs
Measured Vitamin D level &lt; 25nmol/L
History of osteoporosis or low-impact fractures
Current or planned prenancy
Severe renal impairment (eGFR &lt; 30)
Current or previous hypercalcemia
Known secondary cause of vitamin D insufficiency (eg. malabsorptive states)
Presence of an active malignancy
Liver cirrhosis
Planned coronary artery or peripheral vascular intervention within next 6 months
Current oral anticoagulation therapy (eg. Warfarin, Dabigatran)
Clopidogrel or anti-epileptic therapy at any stage of the trial periodo	Any known hypersensitivity to Vitamin D (cholecalciferol)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>All patients admitted to the Cardiology services at the Alfred Hospital are screened for eligibility. 
Allocation is by sealed opaque envelopes generated randomly by clinical trails section in Alfred Hospital pharmacy</concealment>
    <sequence>Random number generation by pharmacy using a randomisation table embedded in Microsoft excel (computerised sequence generationa).</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>1/05/2013</anticipatedstartdate>
    <actualstartdate>1/05/2013</actualstartdate>
    <anticipatedenddate>15/12/2013</anticipatedenddate>
    <actualenddate>1/12/2013</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize>30</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Alfred Health</primarysponsorname>
    <primarysponsoraddress>Commercial Road
Prahran Vic 3181</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Supported by NHMRC program grant</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to investigate the potentially beneficial effects of Vitamin D supplementation on platelet aggregation and endothelial function, in patients who have proven vitamin D insufficiency and a known history of either Coronary artery disease (CAD) or Peripheral Vascular Disease (PVD).</summary>
    <trialwebsite />
    <publication>Nutr Metab Cardiovasc Dis. 2015 Mar;25(3):274-9. doi: 10.1016/j.numecd.2014.12.005. Epub 2014 Dec 23.
Circulating vitamin D levels are associated with the presence and severity of coronary artery disease but not peripheral arterial disease in patients undergoing coronary angiography.
Liew JY1, Sasha SR1, Ngu PJ2, Warren JL1, Wark J3, Dart AM2, Shaw JA4.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alfred Research and Ethics Commitee</ethicname>
      <ethicaddress>The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria 3004, Australia</ethicaddress>
      <ethicapprovaldate>11/12/2012</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>22/10/2012</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Phillip Ngu</name>
      <address>Heart Centre
Alfred Hospital
Commercial Road
Prahran Vic 3181</address>
      <phone>+61 3 90762461</phone>
      <fax />
      <email>Phillip.j.ngu@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Phillip Ngu</name>
      <address>Heart Centre
Alfred Hospital
Commercial Road
Prahran Vic 3181</address>
      <phone>+61 3 90762461</phone>
      <fax />
      <email>Phillip.j.ngu@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>James Shaw</name>
      <address>Heart Centre Alfred Hospital Commercial Road Prahran Vic 3181  </address>
      <phone>+61 3 9076 3263</phone>
      <fax />
      <email>j.shaw@alfred.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>